A. Ehrmann

Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines

I. Kovalenko, Andrea Glasauer, L. Schöckel, 2016, PloS one.

Pharmacological inhibition of Vanin-1 is not protective in models of acute and chronic kidney disease.

A. Ehrmann, F. Eitner, K. Lustig, 2020, American journal of physiology. Renal physiology.

Dissection of glutathione conjugate turnover in yeast.

A. Ehrmann, E. Grill, T. Letzel, 2010, Phytochemistry.

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I

A. Ehrmann, K. Thierauch, K. Ziegelbauer, 2013, Cancer medicine.

The RESOLUTE consortium: unlocking SLC transporters for drug discovery

D. Kell, G. Superti-Furga, R. Everley, 2020, Nature Reviews Drug Discovery.

Evolutionary Morphing of Tryptophan Synthase: Functional Mechanisms for the Enzymatic Channeling of Indole.

O. Mayans, A. Ehrmann, R. Sterner, 2018, Journal of molecular biology.

Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179.

A. Ehrmann, Sven Christian, R. Hillig, 2022, ACS medicinal chemistry letters.